Logo

Aarti Drugs Ltd. Share Price

Pharmaceuticals & Drugs

Aarti Drugs Ltd. (INR)357.45-0.8   (-0.2%)

Exchange ScripsBSE524348NSEAARTIDRUGSISININE767A01016

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Aarti Drugs Ltd. Performance

Market performance

Open price359.5
High361.55
Volumes108833
Prev Close357.45
Low352.6
Closing date2025-04-17

Historical performance

1 Year High635.00
3 Year High645.75
5 Year High1026.95
1 Year Low312.00
3 Year Low312.00
5 Year Low159.24

Aarti Drugs Ltd. Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
3262
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
19.17
Dividend Yield
Dividend Yield
0.03 %

Aarti Drugs Ltd. Investment Returns

1 Year
-27.8%
3 Years
-29.8%
5 Years
113.3%
10 Years
87.4%

Aarti Drugs Ltd. Technicals

IndicatorsValueSignal
5-DMA344.5Bullish
10-DMA339.85Bullish
20-DMA344.19Bullish
50-DMA366.16Bearish
100-DMA402.67Bearish
200-DMA460.7Bearish

Shareholding Pattern

FieldDec-2024Sep-2024Jun-2024Mar-2024Dec-2023
Promoters4141414141
Foreign Investors---------------
Domestic Investors4141414141
Public Investors175965190240150177157506170373
Government---------------

Aarti Drugs Ltd. Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income402211345
Operating Profit3249311634394449
Interest379371239262
Depreciation514503500499
Profit Before Tax2355224227003690
Consolidated Net Profit1714166320502804
Adjusted EPS19182230

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital919926926932
Total Reserves118961099894388202
Minority Interest42-1---
Total Non-Current Liabilities3549279323162572
Total Liabilities24324242142208017660
Capital Work in Progress22521868767193
Total Assets24324242142208017660

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities358913337041550
Cash Flow from Investing Activities-2237-1640-1496-718
Cash Flow from Financing Activitie-1360165920-811
Net Cash Inflow / Outflow-8-14112820
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 19.17.
  • 3Y Stock Price CAGR of the stock is -10.1.
  • The stock has a beta of 0.7.
  • In the last financial year, the company had an EBITDA of ₹3249 Million.
  • The company generated revenue of ₹25286 Million in the previous financial year.

Aarti Drugs Ltd.

357.45-0.8   (-0.2%)

Investment Amount: ₹ 1000000
Current Value: ₹ 724536.3
No. of Shares: 2027.0
Performance:-27.5%
P/L: ₹-275463.7

Top Gainers

SymbolChange%
SECMARK124.29(20%)
OSWALGREEN43.33(18%)
FACT760.85(14%)
OSWALAGRO96.73(13%)
SMSLIFE1435.2(13%)

Top Losers

SymbolChange%
VIKASLIFE2.59(-9%)
ROML50.49(-7%)
ROSSELLIND77.66(-6%)
DYNPRO291(-6%)
SONATSOFTW314.7(-6%)
TREJHARA232.28(-6%)
GATECHDVR1.05(-5%)
MGEL14.23(-5%)

Similar stocks

Aarey Drugs & Pharmaceuticals Ltd.

65.8

56.06

March 20 - April 20

Brooks Laboratories Ltd.

41.3

139.77

March 20 - April 20

SMS Lifesciences India Ltd.

37.2

1435.2

March 20 - April 20

Panacea Biotec Ltd.

33.5

522.95

March 20 - April 20

Bal Pharma Ltd.

28.9

104.91

March 20 - April 20

Kopran Ltd.

27.8

202.58

March 20 - April 20

Wanbury Ltd.

27.2

263.47

March 20 - April 20

Hester Biosciences Ltd.

24.5

1774.9

March 20 - April 20

Announcing Stock of the Month!

Stock of the Month
Stock of the Month